Pinnacle Wealth Planning Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$122K	Hold	12,778	–	–	0.01%	698
2025 Q4	$99.7K	Hold	12,778	–	–	0.01%	790
2025 Q3	$97K	Sell	12,778 -4,184	-25%	-$34.8K	0.01%	469
2025 Q2	$152K	Buy	16,962 +4,048	+31%	+$37.7K	0.02%	433
2025 Q1	$96.9K	Buy	12,914 +204	+2%	+$1.65K	0.01%	384
2024 Q4	$95.6K	Sell	12,710 -12,034	-49%	-$91.4K	0.01%	373
2024 Q3	$188K	Buy	24,744 +1,708	+7%	+$13K	0.03%	468
2024 Q2	$142K	Buy	+23,036	New	+$127K	0.02%	449
2024 Q1	–	Sell	-20,561	Closed	-$123K	–	512
2023 Q4	$123K	Buy	+20,561	New	+$119K	0.02%	440
2021 Q1	–	Sell	-143	Closed	-$1K	–	519
2020 Q4	$1K	Buy	+143	New	+$737	﹤0.01%	2062